The UT Surgical Oncology team consists of nationally recognized leaders in their surgical specialties, many years of expertise and experience in surgical oncology research, clinical studies and (coursebased) teaching, ensuring that all patients receive compassionate, precise cancer treatment. We believe that advanced oncology care requires a multidisciplinary approach and we work closely with referring physicians, patients and other oncologists to ensure excellence in care. Communicating with everyone involved is vital in the planning of cancer care and instrumental to us.
Dr. Ismail Jatoi is Professor and Chief of the Division of Surgical Oncology and Endocrine Surgery at the University of Texas Health Science Center in San Antonio, Texas. He obtained his undergraduate bachelor's degree from Washington University in St. Louis and his MD and PhD degrees from St. Louis University. He is a diplomate of the American Board of Surgery and a fellow of the American College of Surgeons. He completed fellowship training in surgical oncology at the Royal Marsden Hospital in London, England. Dr. Jatoi served in the U.S. military for many years, and was a Professor of Surgery at the Uniformed Services University in Bethesda, Maryland. He retired from the U.S. Army with the rank of Colonel. Dr. Jatoi has had a longstanding interest in the treatment of breast cancer, the management of women at increased risk for breast cancer, and cancer epidemiology.
Dr. Oliver graduated from the University of Texas Medical School at Galveston, where he was awarded the Singleton Surgical Society Award. He completed his General Surgery training at Bexar County Hospital in San Antonio in 1975. Dr. Oliver then completed a Clinical Fellowship in Surgical Oncology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. He has been on the Clinical Faculty in the Department of Surgery at the University of Texas Health Science Center San Antonio since 1975. He is well known regionally as an expert in the surgical management of thyroid and parathyroid disease. His interest and expertise include the management of both benign and malignant breast disease. He is well known to the San Antonio community having previously served as both Chief of Staff and Chief of Surgery at the Metropolitan Hospital, and Chief of Surgery at the Nix Medical Center. His distinguished career has earned him a Texas Monthly "Top Doctor" award in the years 2004-2010.
Anatolio B. Cruz, Jr., MD, Professor of Surgery, Surgical Oncology & Endocrine Surgery
Email | Biosketch
Clinical Professor at the University of Texas Health Science Center at San Antonio. Dr. Cruz, a surgical specialist trained at the University of Minnesota, was the first UTHSCSA chief of surgical oncology; Dr. Cruz recently semi-retired after 35 years with the university. Dr. Cruz was principal investigator for the National Surgical Adjuvant Breast and Bowel Project at UTHSCSA, and helping prove that lumpectomy or segmental mastectomy was as effective as total mastectomy in cure rates and was less mutilating. He also was instrumental in promoting the blue dye-radioisotope sentinel node biopsy procedure on lymph nodes in a patient's axilla, which is now being widely tested throughout the US and Canada.
Meeghan A. Lautner, MD, MDSc, Assistant Professor / Clinical, Surgical Oncology & Endocrine Surgery
Email | Biosketch
Dr. Lautner comes to our Breast Center of Excellence from MD Anderson Cancer Center in Houston, after completing a fellowship in Breast Surgical Oncology which provided advanced knowledge and skills in the surgical and multidisciplinary management of breast cancer. She attended medical school at Wayne State University in Detroit, Michigan, and completed her general surgical residency at the UT Health Science Center San Antonio. Dr. Lautner's clinical practice focuses on the surgical management of both malignant and benign breast disease. This includes procedures such as lumpectomy, skin sparing mastectomy, nipple sparing mastectomy and assessment of axillary lymph nodes. Her research interests include barriers in access to care for breast cancer and cancer pain.
Deborah Seigler, MPAS, PA-C, Faculty Associate
Email | Biosketch
Deborah E. Seigler, BHS, MPAS, PA-C, a native of North Carolina, graduated magna cum laude from Duke University's PA Program in 1977. She has 20 years of Oncology experience beginning at M.D. Anderson Cancer Center where she specialized in GI malignancies. Currently, Deborah is on the faculty at the University of Texas Health Science Center San Antonio (UTHSCSA) in the Division of Surgical Oncology and Endocrine Surgery. UTHSCSA in partnership with University Hospital System (UHS) has a strong breast cancer program serving large numbers of underserved Hispanic women in San Antonio and is recognized as a Breast Center of Excellence by the National Consortium of Breast Centers. Deborah's current efforts are focused on establishing a high risk cancer screening and genetics component to the Division of Surgical Oncology and Endocrine Surgery. Deborah has co- authored over 30 book chapters, articles, abstracts and patient care manuals, which are available on request.
Surgical Oncology Research Faculty
Thelma C. Hurd, MD, Associate Professor, Surgical Oncology & Endocrine Surgery
Email | Biosketch
Dr. Hurd is a Surgical Oncologist, Associate Professor of Surgery and Clinical Assistant Professor in the Department of Biostatistics and Epidemiology at the University of Texas Health Science Center at San Antonio in San Antonio (UTHSCSA), Texas. She is an Adjunct Associate Professor at the UT School of Public Health Houston- San Antonio Extension.
Dr. Hurd's primary research has focused on markers of breast cancer progression, special surgical techniques such as skin sparing mastectomy and lymphatic mapping/sentinel node biopsy and health disparities in underserved populations. Since 2002, Dr. Hurd's research has focused upon health disparities in underserved populations. Currently, Dr. Hurd is a co-investigator on the UTHSCSA CTSA center grant and serves as the Co-Director of the Community Outreach Participation Engagement (COPE) within the community engagement core. The COPE Resource Center's mission is to decrease health disparities among underserved populations in South Texas. To this end, it links communities with academia to increase access to T3/T4 translational research and decrease health disparities via initiatives that specifically address communities' health needs. Dr. Hurd maintains a very active community service record and served as the Director of the Witness Project of Buffalo, and the Witness Project of Niagara. She has received multiple awards for outstanding contributions to healthcare and community outreach in Western New York that include Uncrown Queens, African-American Achiever Award (Roswell Park Cancer Institute), Outstanding Christian Board of Education, Alpha Kappa Alpha, and a New York State Congressional Citation. She is a nine time recipient of the Best of Doctors in America Destination.